[go: up one dir, main page]

GB9315846D0 - Tumour inhibitors - Google Patents

Tumour inhibitors

Info

Publication number
GB9315846D0
GB9315846D0 GB939315846A GB9315846A GB9315846D0 GB 9315846 D0 GB9315846 D0 GB 9315846D0 GB 939315846 A GB939315846 A GB 939315846A GB 9315846 A GB9315846 A GB 9315846A GB 9315846 D0 GB9315846 D0 GB 9315846D0
Authority
GB
United Kingdom
Prior art keywords
tumour
inhibitors
tumour inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939315846A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GB939315846A priority Critical patent/GB9315846D0/en
Publication of GB9315846D0 publication Critical patent/GB9315846D0/en
Priority to PCT/GB1994/001676 priority patent/WO1995003809A2/en
Priority to AU72692/94A priority patent/AU7269294A/en
Pending legal-status Critical Current

Links

GB939315846A 1993-07-30 1993-07-30 Tumour inhibitors Pending GB9315846D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939315846A GB9315846D0 (en) 1993-07-30 1993-07-30 Tumour inhibitors
PCT/GB1994/001676 WO1995003809A2 (en) 1993-07-30 1994-08-01 Use of glucokinase inhibitors for the manufacture of a medicament for treating tumours
AU72692/94A AU7269294A (en) 1993-07-30 1994-08-01 Use of glucokinase inhibitors for the manufacture of a medicament for treating tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315846A GB9315846D0 (en) 1993-07-30 1993-07-30 Tumour inhibitors

Publications (1)

Publication Number Publication Date
GB9315846D0 true GB9315846D0 (en) 1993-09-15

Family

ID=10739734

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939315846A Pending GB9315846D0 (en) 1993-07-30 1993-07-30 Tumour inhibitors

Country Status (3)

Country Link
AU (1) AU7269294A (en)
GB (1) GB9315846D0 (en)
WO (1) WO1995003809A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
UA81743C2 (en) 2000-08-07 2008-02-11 Центокор, Инк. HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS
US7666459B2 (en) 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
US20070207198A1 (en) * 2003-09-17 2007-09-06 Beijing Sino-Hong Kong Dafu Science & Technology Of Biowave Co., Ltd. Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
FR2869541B1 (en) 2004-04-30 2007-12-28 Expanscience Sa Lab USE OF A COMPOSITION COMPRISING D-MANNOHEPTULOSE AND / OR PERSEITOL FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH A CHANGE IN INITIATED IMMUNITY
EP1757296A4 (en) * 2004-05-26 2010-09-01 Rare Sugar Production Technica Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
MX2009008166A (en) 2007-02-01 2009-08-12 Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts.
US8563730B2 (en) 2008-05-16 2013-10-22 Takeda San Diego, Inc. Pyrazole and fused pyrazole glucokinase activators
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
FR2953722B1 (en) 2009-12-16 2012-03-09 Expanscience Lab COMPOSITION COMPRISING AT LEAST ONE C7 SUGAR FOR THE TREATMENT OF ALOPECIA, FOR THE COSMETIC TREATMENT OF PHANES, AND FOR THE CARE OF HAIR, CILES OR NAILS
WO2012012390A1 (en) 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
FR3001889B1 (en) 2013-02-11 2021-02-12 Expanscience Lab USE OF A COMPOSITION CONTAINING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249008B1 (en) * 1986-05-09 1993-09-15 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Use of specific monosaccharides for the preparation of a medicament for the prevention of metastases of malignic tumours
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent

Also Published As

Publication number Publication date
WO1995003809A3 (en) 1995-03-16
AU7269294A (en) 1995-02-28
WO1995003809A2 (en) 1995-02-09

Similar Documents

Publication Publication Date Title
IL108075A0 (en) Enzyme inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
GB9419218D0 (en) Methods
HU9302080D0 (en) Amine-diole protease inhibitors
SG50622A1 (en) Rom-ram disk
EP0601322A3 (en) Adenosindeaminase inhibitor.
GB9315846D0 (en) Tumour inhibitors
EP0722436A4 (en) Mercaptosulfide metalloproteinase inhibitors
HU9503783D0 (en) Squvalen syntetase inhibitors
ZA934970B (en) Enzyme inhibitors
GB9315306D0 (en) Methods
GB2291797B (en) Cases
ZA939480B (en) Enzyme inhibitor
GB9315351D0 (en) Methods
GB9315340D0 (en) Methods
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
GB9307610D0 (en) Deepwood special effects
ZA948312B (en) Corrosion inhibitors
GB9308780D0 (en) Methods
GB9315298D0 (en) Methods
GB9324803D0 (en) Enzyme inhibitors
ZA945085B (en) 5-Lipoxygenase inhibitors
GB9315341D0 (en) Methods
GB9315271D0 (en) Methods
GB9319252D0 (en) Pathway inhibitors